AMACR and carcinoma: The oncogenic role of AMACR in driving tumor growth was first unraveled in prostatic intraepithelial neoplasia and adenocarcinomas by cDNA microarray analysis [24-26], which, albeit with variable prognostic implication, was subsequently reported in several other carcinoma types [27-30].